TY - JOUR AU - Wynn, D; Kaufman, M; Montalban, X TI - Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta JO - Lancet Neurol IS - 4 VL - 9 PY - 2010 DO - 10.1016/S1474-4422(10)70033-8 SP - 381 EP - 390 N1 - , et al; CHOICE investigators. ER -